ArticleNPJ digital medicine2025
Regulatory considerations for successful implementation of digital endpoints in clinical trials for drug development.
Gül Erdemli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it